NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $227,755 | -53.8% | 5,147 | -42.0% | 0.00% | – |
Q1 2023 | $492,684 | +37.9% | 8,874 | -0.2% | 0.00% | -100.0% |
Q4 2022 | $357,312 | -15.5% | 8,895 | -8.1% | 0.00% | 0.0% |
Q3 2022 | $423,000 | +32.6% | 9,676 | +7.4% | 0.00% | 0.0% |
Q2 2022 | $319,000 | -66.9% | 9,007 | -62.0% | 0.00% | -66.7% |
Q1 2022 | $965,000 | -76.7% | 23,726 | -46.4% | 0.00% | -78.6% |
Q4 2021 | $4,137,000 | +1075.3% | 44,300 | +1303.2% | 0.01% | +1300.0% |
Q3 2021 | $352,000 | -55.6% | 3,157 | -54.7% | 0.00% | -66.7% |
Q2 2021 | $792,000 | -48.0% | 6,973 | -53.5% | 0.00% | -50.0% |
Q1 2021 | $1,522,000 | -56.8% | 14,984 | -57.7% | 0.01% | -60.0% |
Q4 2020 | $3,523,000 | +198.3% | 35,400 | +116.6% | 0.02% | +150.0% |
Q3 2020 | $1,181,000 | -31.7% | 16,340 | -52.9% | 0.01% | -45.5% |
Q2 2020 | $1,730,000 | +440.6% | 34,700 | +265.3% | 0.01% | +450.0% |
Q4 2019 | $320,000 | +1423.8% | 9,500 | +990.7% | 0.00% | – |
Q3 2018 | $21,000 | -90.6% | 871 | -92.7% | 0.00% | -100.0% |
Q2 2018 | $224,000 | – | 11,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 3,100,560 | $314,831,000 | 18.93% |
Blue Water Life Science Advisors, LP | 328,836 | $33,390,000 | 16.31% |
Foresite Capital Management III, LLC | 127,305 | $12,927,000 | 11.35% |
HWG Holdings LP | 148,794 | $15,109,000 | 7.53% |
Eagle Health Investments LP | 168,394 | $17,099,000 | 6.71% |
Lagoda Investment Management, L.P. | 103,325 | $10,492,000 | 5.24% |
Ally Bridge Group (NY) LLC | 218,000 | $22,136,000 | 4.24% |
PERKINS CAPITAL MANAGEMENT INC | 63,950 | $6,493,000 | 3.76% |
BRIDGER MANAGEMENT, LLC | 388,620 | $39,460,000 | 3.68% |
Hudson Executive Capital LP | 527,086 | $53,520,000 | 3.32% |